hUC-MSCs Are Unique: Are the Biomaterials, Bioprocesses, & Clinical Product Developers Now “in… July 27, 2021 Cell Therapy, MSCs & Characterization
It’s Not Rocket Science – “MSC-EVs” Have the Right Stuff July 14, 2021 Biomanufacturing, Cell Therapy, EVs & Exosomes, MSCs & Characterization
Genetically Engineered Mesenchymal Stromal Cells (MSCs): A Promising Tool for the Successful Delivery of… June 25, 2021 Cell Therapy, EVs & Exosomes, Genetic Engineering
Environmental Analysis of Therapeutic hMSC Manufacturing: A Comparison of Multiple Bioprocess Systems June 08, 2021 Biomanufacturing, Quality & Regulatory
Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
Critical Quality Attributes (CQAs): Know Their Importance & Limitations in Product & Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
“Known Unknowns” Affect Critical Process Parameters & Critical Quality Attributes in the… April 22, 2021 Biomanufacturing, Quality & Regulatory
Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
